Table 2.
Groups | Serum ALT (U/L) | Hepatic malondialdehyde (nmol/g tissue) | Hepatic glutathione reduced (nmol/g tissue) | Hepatic superoxide dismutase (U/g tissue) |
---|---|---|---|---|
Control | 20.0±1.53 | 31.94±03.0 | 500.2±45.6 | 1213.0±062.7 |
Gossypin | 22.0±0.60 | 28.55±00.6 | 488.5±33.1 | 1268.0±111.4 |
MTX | 57.1±4.76* | 78.39±18.6* | 281.1±24.5* | 0521.1±065.1* |
MTX + gossypin | 24.7±2.33# | 37.07±03.9# | 418.4±32.9# | 1131.0±234.5# |
*,# Significantly different from the control group and MTX group, respectively, at P<0.05. All parameters are expressed as mean±SEM (n=6). MTX=Methotrexate, ALT=Alanine transaminase, SEM=Standard error of mean